Annalisa D'Andrea

Annalisa D'Andrea is a highly accomplished scientist with extensive experience in immunology and inflammation. Currently serving as Chief Scientific Officer at Immunitas Therapeutics and an Independent Board Director at Engimmune Therapeutics, D'Andrea has also held significant roles, including Venture Partner at Longwood Fund and President and Chief Scientific Officer at ImmuneID. Prior experience includes Chief Scientific Officer at Kiniksa Pharmaceuticals and VP, Global Head Immunology & Inflammation Discovery at Roche, where D'Andrea led global discovery strategies in drug development. With a strong background in basic research and project management accumulated over two decades at SRI International, along with prior roles at Chiron Vaccines and DNAX Research Institute, D'Andrea has demonstrated substantial expertise in immunological research and drug discovery. Educational achievements include a PhD in Immunology from Università degli Studi di Firenze and a Master in Biology from Università di Siena.